About Eigen Bio
Genesis focuses on drug discovery and development. Eigen Insights brings together our data and AI training business, ORIGIN, and Paladin.
Our purpose
New York · Seoul · San Francisco
We connect molecular science, computational biology, and AI to build therapeutic programs and put biological intelligence to work.
Eigen Bio studies the regulatory programs that shape disease, response to treatment, and resistance. Our scientific foundation brings Eigen-1, our regulatory foundation model, together with EigenField, our mechanistic knowledge graph.
That foundation supports two distinct businesses. Genesis connects biological hypotheses with drug evaluation and experimental validation. Eigen Insights applies the same scientific expertise through data, products and services for AI teams, research organizations, patients and families.
Explore our researchOur businesses
Genesis develops therapeutic opportunities. Eigen Insights delivers biological intelligence through data, products and services. Both draw on Eigen Bio’s scientific foundation.
A drug discovery and development business that connects disease biology, mechanistic evidence, target qualification, drug asset evaluation and experimental validation.
A business built around three offerings: data and AI training, ORIGIN, and Paladin. Each applies biological expertise to a defined customer or research need.
Leadership & team
Expertise across biological measurement, AI systems, translational research and company building.
CEO & Founder
Three-time founder with a background as a data scientist and quantitative engineer. Author of Hamiltonian Biology and The Dark Genome, which develop a first-principles framework for treating RNA as biology's universal causal interface.
LinkedIn
Chief Intelligence Officer & Co-Founder
Repeat founder who translates frontier AI research into deployable biological and commercial systems. PhD candidate at Korea University with deep expertise in ML engineering and large-model training.
LinkedIn
Chief Science Officer
RNA biologist with deep experience translating transcriptomic science into commercial programs at Guardant Health and Veracyte. Combines molecular biology depth with the program-building discipline required to run rigorous wet-lab science at scale.
LinkedIn
Principal Scientist — Organoids
Organoid scientist trained in the Hans Clevers lineage, the laboratory that invented organoid technology. Deep experience translating tissue models into predictive drug response systems.
LinkedIn
Chief People Officer
Operator and talent leader with prior experience at GIC, McKinsey & Company, and Antler, spanning sovereign capital and early-stage venture building.
LinkedInScientific advisory board
Scientific guidance across RNA biology, pathology, diagnostics, and drug discovery.
Korea University Hospital
Gene Company
HUFS
Intelligene
MD Anderson Cancer Center
SKKU
Affiliations are shown for professional context. They do not indicate institutional partnerships or endorsements.
Contact Eigen Bio
Connect with Genesis or Eigen Insights about a therapeutic program, research project, or commercial partnership.
